Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346049 | 0.79 | CYP11B1 (0.36) | — | |
| SCHEMBL31346074 | 0.78 | DPP4 (0.30) | DPP4TTR | |
| SCHEMBL31346069 | 0.78 | KDM1A (0.36) | TTR | |
| SCHEMBL31346081 | 0.78 | EZH2 (0.33) | — | |
| SCHEMBL31346115 | 0.76 | CTSS (0.36) | — | |
| SCHEMBL31346064 | 0.73 | TTR (0.31) | TTR | |
| SCHEMBL31346027 | 0.72 | — | — | |
| SCHEMBL31346035 | 0.70 | SLC6A2 (0.36) | — | |
| SCHEMBL31345970 | 0.68 | TTR (0.32) | TTR | |
| SCHEMBL31346103 | 0.66 | FFAR1 (0.35) | TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |